Stock BIIB BIOGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Biogen Inc.

Equities

BIIB

US09062X1037

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		Pre-market 08:57:04 am
225.4 USD -2.83% Intraday chart for Biogen Inc. 224.2 -0.55%
01:00pm US FDA advisers to review Eli Lilly Alzheimer's drug RE
09:44am Biogen, Eisai Say Alzheimer's Maintenance Treatment Application Accepted by US FDA MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lost Money on Biogen Inc.(BIIB)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
PR
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
GL
FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
PR
Biogen Inc. Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against (BIIB) - Contact Kessler Topaz Meltzer & Check, LLP
PR
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with Losses to Contact the Firm
BU
Biogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB
PR
FINAL DEADLINE RAPIDLY APPROACHING: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm
PR
Investors who lost money on Biogen Inc. (BIIB) should contact The Gross Law Firm about pending Class Action - BIIB
PR
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)
BU
Class Action Filed Against Biogen Inc. (BIIB) - July 22, 2024 Deadline to Join - Contact Levi & Korsinsky
PR
Robbins LLP Urges BIIB Investors With Large Losses to Contact the Firm for Information About the Biogen Inc. Class Action
BU
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)
BU
Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel
GL
Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel
AQ
NASDAQ: BIIB: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Biogen Inc.
BU
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
BU
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIB
PR
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
GL
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
AQ
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIIB Stock
  4. News Biogen Inc.
  5. Press Releases